Voyager Therapeut (VYGR)
2.95 x 10 3.25 x 1
Post-market by (Cboe BZX)
3.17 +0.18 (+6.02%) 04/11/25 [NASDAQ]
2.95 x 10 3.25 x 1
Post-market 3.17 unch (unch) 16:02 ET
for Fri, Apr 11th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -65,002 | 132,330 | -46,408 | -71,197 | 36,741 |
| Depreciation Amortization | -3,238 | 815 | 6,175 | 5,514 | 3,844 |
| Accounts receivable | 81,311 | -83,234 | 475 | 7,280 | 10,484 |
| Accounts payable and accrued liabilities | 2,392 | -962 | 1,992 | -60 | -3,436 |
| Other Working Capital | 34,859 | -66,557 | 20,471 | 3,294 | -144,537 |
| Other Operating Activity | -65,632 | 95,527 | 4,786 | 1,644 | 188 |
| Operating Cash Flow | $-15,310 | $77,919 | $-12,509 | $-53,525 | $-96,716 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,521 | -3,256 | -2,491 | -1,609 | -12,097 |
| Purchase Of Investment | -465,685 | -223,968 | -54,848 | -15,117 | -70,403 |
| Sale Of Investment | 374,347 | 85,581 | 50,000 | 82,632 | 195,495 |
| Investing Cash Flow | $-94,859 | $-141,643 | $-7,339 | $65,906 | $112,995 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 114,015 | 33,645 | 1,110 | 612 | 3,163 |
| Financing Cash Flow | $114,015 | $33,645 | $1,110 | $612 | $3,163 |
| Beginning Cash Position | 70,395 | 100,474 | 119,212 | 106,219 | 86,777 |
| End Cash Position | 74,241 | 70,395 | 100,474 | 119,212 | 106,219 |
| Net Cash Flow | $3,846 | $-30,079 | $-18,738 | $12,993 | $19,442 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,310 | 77,919 | -12,509 | -53,525 | -96,716 |
| Capital Expenditure | -3,521 | -3,256 | -2,491 | -1,609 | -12,097 |
| Free Cash Flow | -18,831 | 74,663 | -15,000 | -55,134 | -108,813 |